Madrigal Pharmaceuticals Inc
MDGL
NASDAQ. Currency in USD
234.83 +171.03 ( +268.07% )
| Name | Role | Year Born |
|---|---|---|
| Dr. Paul A. Friedman M.D. | Chairman & CEO | - |
| Dr. Rebecca A. Taub M.D. | Founder, Chief Medical Officer, Pres of R&D and Director | - |
| Mr. Alex G. Howarth | Sr. VP & CFO | - |
| Mr. Brian J. Lynch J.D. | Sr. VP & Gen. Counsel | - |
| Mr. Remy Sukhija | Sr. VP & Chief Commercial Officer | - |
| Dr. Kianoush Motesharei Ph.d. | Sr. VP of Bus. & Corp. Devel. | - |
| Mr. Edward Chiang | Sr. VP of Clinical & Technical Operations | - |
| Mr. Thomas W. Hare | Sr. VP of Clinical Management | - |
| Dr. Robert E. Waltermire Ph.D. | Chief Pharmaceutical Devel. Officer | - |
| Dr. Stephen Dodge M.B.A., Pharm.D. | Sr. VP of Global Medical Affairs | - |